share_log

UBS Downgrades Cabot to Neutral, Lowers Price Target to $87

Benzinga ·  Jan 8 20:17

UBS analyst Joshua Spector downgrades Cabot (NYSE:CBT) from Buy to Neutral and lowers the price target from $90 to $87.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment